123 related articles for article (PubMed ID: 37610106)
1. Improving the Health of People Who Inject Drugs Through COVID-19-Related Policies.
Hill K; Thakarar K; Eslinger H; Prosperino L; Sue KL
Public Health Rep; 2023; 138(6):862-864. PubMed ID: 37610106
[No Abstract] [Full Text] [Related]
2. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated with HIV Testing Among People Who Inject Drugs: Findings from a Multistate Study at the Start of the COVID-19 Pandemic.
Allen ST; Schneider KE; Morris M; Saloner B; Sherman SG
AIDS Behav; 2023 May; 27(5):1674-1681. PubMed ID: 36327014
[TBL] [Abstract][Full Text] [Related]
4. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
[TBL] [Abstract][Full Text] [Related]
5. A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic.
Bradley H; Austin C; Allen ST; Asher A; Bartholomew TS; Board A; Borquez A; Buchacz K; Carter A; Cooper HLF; Feinberg J; Furukawa N; Genberg B; Gorbach PM; Hagan H; Huriaux E; Hurley H; Luisi N; Martin NK; Rosenberg ES; Strathdee SA; Jarlais DCD
Int J Drug Policy; 2022 Dec; 110():103889. PubMed ID: 36343431
[TBL] [Abstract][Full Text] [Related]
6. Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery.
Shaw G; Schaefer R; Schmidt HA; Madden A; Chang J; Mozalevskis A; Msimanga-Radebe B; Mangadan Konath N; Verster A; Baggaley R; Rodolph M; Macdonald V
Harm Reduct J; 2023 Feb; 20(1):16. PubMed ID: 36782321
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with receptive injection equipment sharing among people who inject drugs: findings from a multistate study at the start of the COVID-19 pandemic.
Allen ST; Schneider KE; Morris M; Rouhani S; Harris SJ; Saloner B; Sherman SG
Harm Reduct J; 2023 Feb; 20(1):18. PubMed ID: 36793041
[TBL] [Abstract][Full Text] [Related]
8. "We don't need services. We have no problems": exploring the experiences of young people who inject drugs in accessing harm reduction services.
Krug A; Hildebrand M; Sun N
J Int AIDS Soc; 2015; 18(2 Suppl 1):19442. PubMed ID: 25724510
[TBL] [Abstract][Full Text] [Related]
9. Supporting the Health of HIV-Positive People Who Inject Drugs During COVID-19 and Beyond: Lessons for the United States from St. Petersburg, Russia.
Carroll JJ; Rossi SL; Vetrova MV; Kiriazova T; Lunze K
Am J Public Health; 2022 Apr; 112(S2):S123-S127. PubMed ID: 35349320
[No Abstract] [Full Text] [Related]
10. Acute infections in people who inject drugs.
Stevenson N; Suttie S; Fernandes E; Rae N
BMJ; 2022 Oct; 379():e072635. PubMed ID: 36207027
[No Abstract] [Full Text] [Related]
11. Health service utilisation and access for people who inject drugs during COVID-19.
Efunnuga H; Higgs P; Walker S; O'Keefe D
Drug Alcohol Rev; 2022 Sep; 41(6):1304-1310. PubMed ID: 35266229
[TBL] [Abstract][Full Text] [Related]
12. Unintended harm: A qualitative study of "harm" upon people who inject drugs in Bangkok, Thailand.
Haritavorn N
Health (London); 2023 Jul; 27(4):525-539. PubMed ID: 34523372
[TBL] [Abstract][Full Text] [Related]
13. Harm reduction interventions for people who inject drugs.
Nelson EU
Lancet Glob Health; 2023 May; 11(5):e632-e633. PubMed ID: 36996859
[No Abstract] [Full Text] [Related]
14. Commentary: the value of PrEP for people who inject drugs.
Coleman RL; McLean S
J Int AIDS Soc; 2016; 19(7(Suppl 6)):21112. PubMed ID: 27760686
[TBL] [Abstract][Full Text] [Related]
15. "Maintaining HIV and HCV prevention and care for people who inject drugs despite COVID-19 in Hai Phong, Vietnam".
Giang HT; Duc NQ; Molès JP; Vinh VH; Nagot N; Thanh NTT; Huong DT; Oanh KTH; Khue PM; Mai LS; Trang NT; Ngoc PT; Quillet C; Feelemyer J; Vallo R; Michel L; Jarlais DD; Laureillard D; Rapoud D
Int J Drug Policy; 2022 Dec; 110():103870. PubMed ID: 36244242
[TBL] [Abstract][Full Text] [Related]
16. HIV and people who inject drugs: inequality until death.
Seguin-Devaux C
Lancet HIV; 2024 Mar; 11(3):e136-e137. PubMed ID: 38280394
[No Abstract] [Full Text] [Related]
17. New guidance on infections in people who inject drugs.
Samarasekera U
Lancet Infect Dis; 2024 Jan; 24(1):e19. PubMed ID: 38141649
[No Abstract] [Full Text] [Related]
18. Factors associated with sharing equipment among people who inject drugs: The role of community attachment in harm reduction and health promotion.
Broady TR; Brener L; Caruana T; Cama E; Treloar C
Drug Alcohol Rev; 2023 Mar; 42(3):561-568. PubMed ID: 36729689
[TBL] [Abstract][Full Text] [Related]
19. Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel.
Wiessing L; Sypsa V; Abagiu AO; Arble A; Berndt N; Bosch A; Buskin S; Chemtob D; Combs B; Conyngham C; Feelemyer J; Fitzgerald M; Goldberg D; Hatzakis A; Patrascu RE; Keenan E; Khan I; Konrad S; Leahy J; McAuley A; Menza T; Merrick S; Metcalfe R; Rademaker T; Revivo S; Rosca P; Seguin-Devaux C; Skinner S; Smith C; Tinsley J; Wilberg M; Des Jarlais D
AIDS Behav; 2023 Apr; 27(4):1140-1153. PubMed ID: 36367613
[TBL] [Abstract][Full Text] [Related]
20. The road to HIV and HCV elimination among people who inject drugs.
Corona-Mata D; Rivero-Juarez A
Lancet Gastroenterol Hepatol; 2023 Jun; 8(6):497-498. PubMed ID: 36996851
[No Abstract] [Full Text] [Related]
[Next] [New Search]
